Featured Research

from universities, journals, and other organizations

Near-infrared imaging system shows promise as future pancreatic cancer diagnostic tool

Date:
August 18, 2011
Source:
Optical Society of America
Summary:
Researchers have demonstrated for the first time that optical coherence tomography (OCT), a high resolution optical imaging technique that works by bouncing near-infrared laser light off biological tissue, can reliably distinguish between pancreatic cysts that are low-risk and high-risk for becoming malignant.

A: Photograph of the OCT instrument and imaging probe; B,B’: Gross appearance and magnified OCT image of the malignant mucinous cystic neoplasmsm (MCN); C,C’: Gross appearance and magnified OCT image of the benign serous cystic adenoma (SCA). MCNs have large cavities, filled with a mucinous fluid that scatters light (see yellow arrow), while SCAs have a honeycomb structure of smaller cavities separated by a tiny septae (see red arrow). The SCA fluid is optically transparent and does not scatter light. OCT scale bar: 500 μm.
Credit: Images courtesy of Dr. Nicusor Iftimia, Physical Sciences Inc. and Dr. William Brugge, Massachusetts General Hospital.

A team of researchers from four Boston-area institutions led by Nicusor Iftimia from Physical Sciences, Inc. has demonstrated for the first time that optical coherence tomography (OCT), a high resolution optical imaging technique that works by bouncing near-infrared laser light off biological tissue, can reliably distinguish between pancreatic cysts that are low-risk and high-risk for becoming malignant. Other optical techniques often fail to provide images that are clear enough for doctors to differentiate between the two types.

Related Articles


To test the diagnostic potential of OCT imaging, researchers used the technique to examine surgically removed pancreatic tissue samples from patients with cystic lesions. By identifying unique features of the high-risk cysts that appeared in the OCT scans, the team developed a set of visual criteria to differentiate between high and low risk cysts. They then tested the criteria by comparing OCT diagnoses to those obtained by examining thin slices of the pancreatic tissue under a microscope. Their results, described in the August issue of the Optical Society's (OSA) open-access journal Biomedical Optics Express, showed that OCT allowed clinicians to reliably differentiate between low-risk and high-risk cysts with a success rate close to that achieved by microscope-assisted examinations of slices of the same samples.

Future studies by the research team will focus on improving imaging resolution to further differentiate between solid lesions and autoimmune pancreatitis, and test this technology in vivo. They recently received FDA approval for testing this technology in human patients by using an OCT probe small enough to be inserted into the pancreas through a biopsy needle, which will be guided into suspect masses in the pancreas by endoscopic ultrasound imaging. A pilot clinical study is planned to start within the next couple of months. If in vivo data will prove reliable differentiation between the two types of cysts, a study in a larger number of patients will be planned, contingent on NIH funding and FDA approval.


Story Source:

The above story is based on materials provided by Optical Society of America. Note: Materials may be edited for content and length.


Journal Reference:

  1. Nicusor Iftimia, Sevdenur Cizginer, Vikram Deshpande, Martha Pitman, Servet Tatli, Nicolae-Adrian Iftimia, Daniel X Hammer, Mircea Mujat, Teoman Ustun, R. Daniel Ferguson, William R. Brugge. Differentiation of pancreatic cysts with optical coherence tomography (OCT) imaging: an ex vivo pilot study. Biomedical Optics Express, 2011; 2 (8): 2372 DOI: 10.1364/BOE.2.002372

Cite This Page:

Optical Society of America. "Near-infrared imaging system shows promise as future pancreatic cancer diagnostic tool." ScienceDaily. ScienceDaily, 18 August 2011. <www.sciencedaily.com/releases/2011/08/110817101953.htm>.
Optical Society of America. (2011, August 18). Near-infrared imaging system shows promise as future pancreatic cancer diagnostic tool. ScienceDaily. Retrieved December 22, 2014 from www.sciencedaily.com/releases/2011/08/110817101953.htm
Optical Society of America. "Near-infrared imaging system shows promise as future pancreatic cancer diagnostic tool." ScienceDaily. www.sciencedaily.com/releases/2011/08/110817101953.htm (accessed December 22, 2014).

Share This


More From ScienceDaily



More Matter & Energy News

Monday, December 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Will New A350 Help Airbus Fly?

Will New A350 Help Airbus Fly?

Reuters - Business Video Online (Dec. 22, 2014) Qatar Airways takes first delivery of Airbus' new A350 passenger jet. As Joel Flynn reports it's the planemaker's response to the Boeing 787 Dreamliner and the culmination of eight years of development. Video provided by Reuters
Powered by NewsLook.com
Man Parachutes Off Lawn Chair Airlifted By Helium Balloons

Man Parachutes Off Lawn Chair Airlifted By Helium Balloons

Buzz60 (Dec. 22, 2014) A BASE jumper rides a lawn chair, a shotgun, and a giant bunch of helium balloons into the sky in what seems like a country version of the movie 'Up." Jen Markham has the story. Video provided by Buzz60
Powered by NewsLook.com
Touch-Free Smart Phone Empowers Mobility-Impaired

Touch-Free Smart Phone Empowers Mobility-Impaired

Reuters - Innovations Video Online (Dec. 21, 2014) A touch-free phone developed in Israel enables the mobility-impaired to operate smart phones with just a movement of the head. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Reuters - Innovations Video Online (Dec. 21, 2014) A team of scientists led by Danish chemist Jorn Christensen says they have isolated two chemical compounds within an existing antipsychotic medication that could be used to help a range of failing antibiotics work against killer bacterial infections, such as Tuberculosis. Jim Drury went to meet him. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Space & Time

Matter & Energy

Computers & Math

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins